Mar 2, 2022 | Cancer Center News
Image of Ling-Jian Meng. Urbana, Ill. – Radiopharmaceutical therapy is an emerging type of radiation therapy with great potential for patients with metastatic cancer, who have diminished prospects for long-term survival. This treatment uses alpha-particles...
May 11, 2021 | Cancer Center News
Urbana, Ill. – A new study, published in JCI insight, looks at how Brd4, a regulator of the innate immune response, influences diet-induced obesity. The researchers believe that Brd4 could be used as a target for obesity and insulin resistance. Approximately one-third...
Mar 23, 2021 | Cancer Center News
Urbana, Ill. – Pengfei Song, an assistant professor of electrical and computer engineering, has received a National Institute of Biomedical Imaging and Bioengineering Trailblazer R21 Award for pursuing the next-generation ultrasound localization microscopy. The award...
Jul 17, 2020 | Cancer Center News
Breast cancer patients are 60 percent more likely to die of cancer after surviving a heart attack, according to a new study published in Nature Medicine. Researchers reported that heart attacks, by blocking blood flow through arteries, trigger a specific, pro-cancer...
Apr 9, 2018 | Cancer Center News
Image of Emerging Pathway of Doxorubin Cardiotoxicity. ABSTRACTDoxorubicin (DOX) is among the oldest and most-used chemotherapeutics. However, its use is limited by a cumulative dose that leads to cardiotoxicity. DOX is an anthracycline quinone that is known to...
